Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BlackRock Inc.BLK · Entity 12961 | Director | June 28, 2024 | July 02, 2024 |
| BlackRock, Inc.BLK · Entity 2850 | Director | September 30, 2026 | October 02, 2026 |
| Royalty Pharma plcRPRX · Entity 3100 | Director | June 30, 2021 | June 30, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BlackRock Inc.
Report date June 28, 2024 · Filed July 02, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,963 |
Reported balance
After 2024-06-28 transaction · row 1
1 source rowRow 1 · 2024-06-28 · Grant · Acquired 42 · Balance 15,963 F1: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $787.32 per share which was the closing price of the stock on June 28, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $787.32 per share which was the closing price of the stock on June 28, 2024.
BlackRock, Inc.
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,743 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 34 · Balance 16,743 F1: Common Stock granted to Nonemployee Directors under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $1,058.29 per share which was the closing price of the stock on September 30, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Common Stock granted to Nonemployee Directors under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $1,058.29 per share which was the closing price of the stock on September 30, 2026.
Royalty Pharma plc
Report date June 30, 2021 · Filed June 30, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Ordinary SharesSEC Table I · non-derivative | Direct | 6,597 |
Reported balance
After 2021-06-30 transaction · row 1
1 source rowRow 1 · 2021-06-30 · Grant · Acquired 871 · Balance 6,597 F1: Reflects Class A Ordinary Shares issued to the Reporting Person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500. |
| Class A Ordinary SharesSEC Table I · non-derivative | IndirectBy Madison Park Capital, LLC | 539,768 |
Reported balance
Holding disclosure · report date 2021-06-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 539,768 F2: The Reporting Person has a private membership interest in Madison Park Capital, LLC ("MPC"), a U.S. based entity within the General Atlantic private equity group, and is an officer and a member of the Board of Managers of MPC. The ordinary shares reported herein give effect to the distribution of ordinary shares by Groton Restricted Fund LP for no additional consideration to its limited partners. As the distribution of such ordinary shares constituted only a change in the form of the Reporting Person's ownership in such ordinary shares, the Reporting Person was not required to report the distribution pursuant to Section 16. The Reporting Person disclaims ownership of such ordinary shares except to the extent he has a pecuniary interest therein. |
| Class A Ordinary SharesSEC Table I · non-derivative | IndirectGA RP Holding, L.P. | 1,500,000 |
Reported balance
Holding disclosure · report date 2021-06-30 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,500,000 F3: The Reporting Person is employed by an entity affiliated with GA RP Holding, L.P. ("GA RP Holding"). The limited partners of GA RP Holding that share beneficial ownership of the ordinary shares held by GA RP Holding are GAP Coinvestments CDA, L.P. ("GAPCO CDA"), GAP Coinvestments III, LLC ("GAPCO III"), GAP Coinvestments IV, L.P. ("GAPCO IV"), GAP Coinvestments V, LLC ("GAPCO V"), General Atlantic Partners (Bermuda) IV, L.P. ("GAP Bermuda IV"), General Atlantic Partners (Bermuda) EU, L.P. ("GAP Bermuda EU") and General Atlantic Partners (Lux), SCSp ("GAP Lux"). F4: GA RP Holding, Ltd. ("GA RP Ltd.") is the general partner of GA RP Holding. General Atlantic LLC ("GA LLC") is the managing member of GAPCO III, GAPCO IV and GAPCO V and the general partner of GAPCO CDA. General Atlantic GenPar (Lux), SCSp ("GA GenPar Lux") is the general partner of GAP Lux, and General Atlantic (Lux) S.a.r.l ("GA Lux Sarl") is the general partner of GA GenPar Lux. General Atlantic GenPar (Bermuda), L.P. ("GA GenPar Bermuda") is the sole shareholder of GA Lux Sarl, and the general partner of GAP Bermuda IV and GAP Bermuda EU. GAP (Bermuda) Limited is the general partner of GA GenPar Bermuda and the sole shareholder of GA RP Ltd. F5: There are nine members of the management committee of GA LLC (the "GA Management Committee"), and the GA Management Committee is ultimately responsible for the management of GAP (Bermuda) Limited. The Reporting Person is a member of the GA Management Committee and is Chief Executive Officer and a Managing Director of GA LLC. F6: GA LLC, GA GenPar Bermuda, GAP (Bermuda) Limited, GAPCO III, GAPCO IV, GAPCO V, GAPCO CDA, GAP Bermuda IV, GAP Bermuda EU, GAP Lux, GA RP Ltd, GA GenPar Lux and GA Lux Sarl are a "group" within the meaning of Rule 13d-5 of the Securities Exchange Act of 1934, as amended. Each of the members of the GA Management Committee disclaims ownership of the ordinary shares except to the extent he or she has a pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects Class A Ordinary Shares issued to the Reporting Person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.
F2: The Reporting Person has a private membership interest in Madison Park Capital, LLC ("MPC"), a U.S. based entity within the General Atlantic private equity group, and is an officer and a member of the Board of Managers of MPC. The ordinary shares reported herein give effect to the distribution of ordinary shares by Groton Restricted Fund LP for no additional consideration to its limited partners. As the distribution of such ordinary shares constituted only a change in the form of the Reporting Person's ownership in such ordinary shares, the Reporting Person was not required to report the distribution pursuant to Section 16. The Reporting Person disclaims ownership of such ordinary shares except to the extent he has a pecuniary interest therein.
F3: The Reporting Person is employed by an entity affiliated with GA RP Holding, L.P. ("GA RP Holding"). The limited partners of GA RP Holding that share beneficial ownership of the ordinary shares held by GA RP Holding are GAP Coinvestments CDA, L.P. ("GAPCO CDA"), GAP Coinvestments III, LLC ("GAPCO III"), GAP Coinvestments IV, L.P. ("GAPCO IV"), GAP Coinvestments V, LLC ("GAPCO V"), General Atlantic Partners (Bermuda) IV, L.P. ("GAP Bermuda IV"), General Atlantic Partners (Bermuda) EU, L.P. ("GAP Bermuda EU") and General Atlantic Partners (Lux), SCSp ("GAP Lux").
F4: GA RP Holding, Ltd. ("GA RP Ltd.") is the general partner of GA RP Holding. General Atlantic LLC ("GA LLC") is the managing member of GAPCO III, GAPCO IV and GAPCO V and the general partner of GAPCO CDA. General Atlantic GenPar (Lux), SCSp ("GA GenPar Lux") is the general partner of GAP Lux, and General Atlantic (Lux) S.a.r.l ("GA Lux Sarl") is the general partner of GA GenPar Lux. General Atlantic GenPar (Bermuda), L.P. ("GA GenPar Bermuda") is the sole shareholder of GA Lux Sarl, and the general partner of GAP Bermuda IV and GAP Bermuda EU. GAP (Bermuda) Limited is the general partner of GA GenPar Bermuda and the sole shareholder of GA RP Ltd.
F5: There are nine members of the management committee of GA LLC (the "GA Management Committee"), and the GA Management Committee is ultimately responsible for the management of GAP (Bermuda) Limited. The Reporting Person is a member of the GA Management Committee and is Chief Executive Officer and a Managing Director of GA LLC.
F6: GA LLC, GA GenPar Bermuda, GAP (Bermuda) Limited, GAPCO III, GAPCO IV, GAPCO V, GAPCO CDA, GAP Bermuda IV, GAP Bermuda EU, GAP Lux, GA RP Ltd, GA GenPar Lux and GA Lux Sarl are a "group" within the meaning of Rule 13d-5 of the Securities Exchange Act of 1934, as amended. Each of the members of the GA Management Committee disclaims ownership of the ordinary shares except to the extent he or she has a pecuniary interest therein.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
IHS Markit Ltd.
Report date February 28, 2022 · Filed March 02, 2022
Section 16 reporting ended · disclosed 2022-03-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-02-28 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2022-02-28 · Disposition to issuer · Disposed 50,621 · Balance 0 F1: Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of November 29, 2020, as amended on January 20, 2021, by and among the issuer, S&P Global Inc. ("S&P Global") and Sapphire Subsidiary, Ltd. (the "Merger Agreement"). F2: Represents shares and deferred stock units. F3: Each common share was converted pursuant to the Merger Agreement into the right to receive 0.2838 (the "Exchange Ratio") fully paid and nonassessable shares of common stock, par value $1.00 per share, of S&P Global ("S&P Global Common Stock"), with cash payable in lieu of any fractional shares. Each equity award was converted pursuant to the Merger Agreement into an equivalent award in respect of S&P Global Common Stock based on the Exchange Ratio, with the same terms and conditions as those that applied immediately prior to the consummation of the merger, except that outstanding performance-based restricted stock units were converted based on target performance and all performance-vesting conditions lapsed with respect thereto. |
| Common SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-02-28 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2022-02-28 · Disposition to issuer · Disposed 1,680 · Balance 0 F1: Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of November 29, 2020, as amended on January 20, 2021, by and among the issuer, S&P Global Inc. ("S&P Global") and Sapphire Subsidiary, Ltd. (the "Merger Agreement"). F4: Represents shares underlying restricted stock units. F3: Each common share was converted pursuant to the Merger Agreement into the right to receive 0.2838 (the "Exchange Ratio") fully paid and nonassessable shares of common stock, par value $1.00 per share, of S&P Global ("S&P Global Common Stock"), with cash payable in lieu of any fractional shares. Each equity award was converted pursuant to the Merger Agreement into an equivalent award in respect of S&P Global Common Stock based on the Exchange Ratio, with the same terms and conditions as those that applied immediately prior to the consummation of the merger, except that outstanding performance-based restricted stock units were converted based on target performance and all performance-vesting conditions lapsed with respect thereto. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of November 29, 2020, as amended on January 20, 2021, by and among the issuer, S&P Global Inc. ("S&P Global") and Sapphire Subsidiary, Ltd. (the "Merger Agreement").
F2: Represents shares and deferred stock units.
F3: Each common share was converted pursuant to the Merger Agreement into the right to receive 0.2838 (the "Exchange Ratio") fully paid and nonassessable shares of common stock, par value $1.00 per share, of S&P Global ("S&P Global Common Stock"), with cash payable in lieu of any fractional shares. Each equity award was converted pursuant to the Merger Agreement into an equivalent award in respect of S&P Global Common Stock based on the Exchange Ratio, with the same terms and conditions as those that applied immediately prior to the consummation of the merger, except that outstanding performance-based restricted stock units were converted based on target performance and all performance-vesting conditions lapsed with respect thereto.
F4: Represents shares underlying restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 2, 2026 21:49 UTC | BlackRock, Inc. BLK · Entity 2850 | GrantCommon Stock | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0002012383-26-003273 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,743 F1 · shares: Common Stock granted to Nonemployee Directors under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $1,058.29 per share which was the closing price of the stock on September 30, 2026. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 22:39 UTC | BlackRock, Inc. BLK · Entity 2850 | GrantCommon Stock | 37 | $0.00 | $0.00 |
DisclosureSEC source: 0002012383-26-001874 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,709 F1 · shares: Common Stock granted to Nonemployee Directors under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $961.56 per share which was the closing price of the stock on June 30, 2026. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:34 UTC | BlackRock, Inc. BLK · Entity 2850 | GrantCommon Stock | 38 | $0.00 | $0.00 |
DisclosureSEC source: 0002012383-26-000940 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,672 F1 · shares: Common Stock granted to Nonemployee Directors under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $961.71 per share which was the closing price of the stock on March 31, 2026. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 23:21 UTC | BlackRock, Inc. BLK · Entity 2850 | GrantCommon Stock | 214 | $0.00 | $0.00 |
DisclosureSEC source: 0002012383-26-000811 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,634 F1 · shares: Restricted Stock Units granted to non-employee directors under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $1,170.18 per share which was the average of the high and low price per share of Common Stock on January 16, 2026. Restricted Stock Units vest upon the director's election or re-election, as applicable, at the 2026 Annual Meeting of Shareholders and will be settled in shares of Common Stock on the third anniversary of the date of grant, unless the director has elected to receive settlement of such shares on the date that he or she ceases to be a member of the Board (either in a lump sum or in five equal annual installments beginning on such date). Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 23:09 UTC | BlackRock, Inc. BLK · Entity 2850 | GrantCommon Stock | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0002012383-26-000002 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,420 F1 · shares: Common Stock granted to Nonemployee Directors under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $1,070.34 per share which was the closing price of the stock on December 31, 2025. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 21:10 UTC | BlackRock, Inc. BLK · Entity 2850 | GrantCommon Stock | 31 | $0.00 | $0.00 |
DisclosureSEC source: 0002012383-25-001618 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,386 F1 · shares: Common Stock granted to Nonemployee Directors under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $1,165.87 per share which was the closing price of the stock on September 30, 2025. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 23:29 UTC | BlackRock, Inc. BLK · Entity 2850 | GrantCommon Stock | 35 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-018736 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,355 F1 · shares: Common Stock granted to Nonemployee Directors under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $1,049.25 per share which was the closing price of the stock on June 30, 2025. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 22:26 UTC | BlackRock, Inc. BLK · Entity 2850 | GrantCommon Stock | 38 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-011218 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,320 F1 · shares: Includes Common Stock granted to Nonemployee Directors under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $946.48 per share which was the closing price of the stock on March 31, 2025. Read SEC document |
| January 16, 2025 Filed Jan 17, 2025 23:18 UTC | BlackRock, Inc. BLK · Entity 2850 | GrantCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-001481 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,282 F1 · shares: Restricted Stock Units granted to non-employee directors under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $999.36 per share which was the average of the high and low price per share of Common Stock on January 16, 2025. Restricted Stock Units vest upon the director's election or re-election, as applicable, at the 2025 Annual Meeting of Shareholders and will be settled in shares of Common Stock on the third anniversary of the date of grant, unless the director has elected to receive settlement of such shares on the date that he or she ceases to be a member of the Board (either in a lump sum or in five equal annual installments beginning on such date). Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 23:27 UTC | BlackRock, Inc. BLK · Entity 2850 | GrantCommon Stock | 35 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-000527 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,032 F1 · shares: Includes Common Stock granted to Nonemployee Directors under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $1,025.11 per share which was the closing price of the stock on December 31, 2024. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 23:51 UTC | BlackRock, Inc. BLK · Entity 2850 | GrantCommon Stock | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-111868 · ownership.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,997 F1 · shares: Includes Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $949.51 per share which was the closing price of the stock on September 30, 2024. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 22:53 UTC | BlackRock Inc. BLK · Entity 12961 | GrantCommon Stock | 42 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-019951 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,963 F1 · shares: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $787.32 per share which was the closing price of the stock on June 28, 2024. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 22:46 UTC | BlackRock Inc. BLK · Entity 12961 | GrantCommon Stock | 39 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-011638 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,921 F1 · shares: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $833.70 per share which was the closing price of the stock on March 28, 2024. Read SEC document |
| January 16, 2024 Filed Jan 19, 2024 02:08 UTC | BlackRock Inc. BLK · Entity 12961 | GrantCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-001658 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,882 F1 · shares: Restricted Stock Units granted to non-employee directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $798.83 per share which was the average of the high and low price per share of Common Stock on January 16, 2024. Restricted Stock Units vest upon the director's election or re-election, as applicable, at the 2024 Annual Meeting of Shareholders and will be settled in shares of Common Stock on the third anniversary of the date of grant, unless the director has elected to receive settlement of such shares on the date that he or she ceases to be a member of the Board (either in a lump sum or in five equal annual installments beginning on such date). Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 23:14 UTC | BlackRock Inc. BLK · Entity 12961 | GrantCommon Stock | 40 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-000589 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,582 F1 · shares: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $811.80 per share which was the closing price of the stock on December 29, 2023. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 21:38 UTC | BlackRock Inc. BLK · Entity 12961 | GrantCommon Stock | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025330 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,542 F1 · shares: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $646.49 per share which was the closing price of the stock on September 29, 2023. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 22:18 UTC | BlackRock Inc. BLK · Entity 12961 | GrantCommon Stock | 47 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-020266 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,492 F1 · shares: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $691.14 per share which was the closing price of the stock on June 30, 2023. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 22:36 UTC | BlackRock Inc. BLK · Entity 12961 | GrantCommon Stock | 49 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-012426 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,445 F1 · shares: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $669.12 per share which was the closing price of the stock on March 31, 2023. Read SEC document |
| January 17, 2023 Filed Jan 20, 2023 00:32 UTC | BlackRock Inc. BLK · Entity 12961 | GrantCommon Stock | 323 | $743.61 | $240,186.03 |
DisclosureSEC source: 0001127602-23-001871 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,396 F1 · shares: Restricted Stock Units granted to non-employee directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $743.61 per share which was the average of the high and low price per share of Common Stock on January 17, 2023. Restricted Stock Units vest upon the director's election or re-election, as applicable, at the 2023 Annual Meeting of Shareholders and will be settled in shares of Common Stock on the third anniversary of the date of grant, unless the director has elected to receive settlement of such shares on the date that he or she ceases to be a member of the Board (either in a lump sum or in five equal annual installments beginning on such date). Read SEC document |
| December 30, 2022 Filed Jan 4, 2023 22:51 UTC | BlackRock Inc. BLK · Entity 12961 | GrantCommon Stock | 45 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-000652 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,073 F1 · shares: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $708.63 per share which was the closing price of the stock on December 30, 2022. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 23:05 UTC | BlackRock Inc. BLK · Entity 12961 | GrantCommon Stock | 59 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023592 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,028 F1 · shares: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $550.28 per share which was the closing price of the stock on September 30, 2022. Read SEC document |
| June 30, 2022 Filed Jul 1, 2022 20:40 UTC | BlackRock Inc. BLK · Entity 12961 | GrantCommon Stock | 54 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018527 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,969 F1 · shares: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $609.04 per share which was the closing price of the stock on June 30, 2022. Read SEC document |
| April 18, 2022 Filed Apr 18, 2022 22:06 UTC | BlackRock Inc. BLK · Entity 12961 | PurchaseCommon Stock | 2,000 | $681.44 | $1,362,880.00 |
DisclosureSEC source: 0001127602-22-012094 · form4.xml · nonDerivative · entry 2 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,915 Read SEC document |
| April 14, 2022 Filed Apr 18, 2022 22:06 UTC | BlackRock Inc. BLK · Entity 12961 | PurchaseCommon Stock | 1,000 | $701.00 | $701,000.00 |
DisclosureSEC source: 0001127602-22-012094 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,915 Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 22:36 UTC | BlackRock Inc. BLK · Entity 12961 | GrantCommon Stock | 43 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-011325 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,915 F1 · shares: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $764.17 per share which was the closing price of the stock on March 31, 2022. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 22:06 UTC | IHS Markit Ltd. INFO · Entity 129710 | Disposition to issuerCommon Shares | 1,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001598014-22-000053 · wf-form4_164625877044845.xml · nonDerivative · entry 2 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of November 29, 2020, as amended on January 20, 2021, by and among the issuer, S&P Global Inc. ("S&P Global") and Sapphire Subsidiary, Ltd. (the "Merger Agreement"). F4 · shares: Represents shares underlying restricted stock units. F3 · price: Each common share was converted pursuant to the Merger Agreement into the right to receive 0.2838 (the "Exchange Ratio") fully paid and nonassessable shares of common stock, par value $1.00 per share, of S&P Global ("S&P Global Common Stock"), with cash payable in lieu of any fractional shares. Each equity award was converted pursuant to the Merger Agreement into an equivalent award in respect of S&P Global Common Stock based on the Exchange Ratio, with the same terms and conditions as those that applied immediately prior to the consummation of the merger, except that outstanding performance-based restricted stock units were converted based on target performance and all performance-vesting conditions lapsed with respect thereto. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 22:06 UTC | IHS Markit Ltd. INFO · Entity 129710 | Disposition to issuerCommon Shares | 50,621 | $0.00 | $0.00 |
DisclosureSEC source: 0001598014-22-000053 · wf-form4_164625877044845.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of November 29, 2020, as amended on January 20, 2021, by and among the issuer, S&P Global Inc. ("S&P Global") and Sapphire Subsidiary, Ltd. (the "Merger Agreement"). F2 · shares: Represents shares and deferred stock units. F3 · price: Each common share was converted pursuant to the Merger Agreement into the right to receive 0.2838 (the "Exchange Ratio") fully paid and nonassessable shares of common stock, par value $1.00 per share, of S&P Global ("S&P Global Common Stock"), with cash payable in lieu of any fractional shares. Each equity award was converted pursuant to the Merger Agreement into an equivalent award in respect of S&P Global Common Stock based on the Exchange Ratio, with the same terms and conditions as those that applied immediately prior to the consummation of the merger, except that outstanding performance-based restricted stock units were converted based on target performance and all performance-vesting conditions lapsed with respect thereto. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 23:22 UTC | BlackRock Inc. BLK · Entity 12961 | GrantCommon Stock | 288 | $832.07 | $239,636.16 |
DisclosureSEC source: 0001127602-22-001763 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,872 F1 · shares: Restricted Stock Units granted to non-employee directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $832.07 per share which was the average of the high and low price per share of Common Stock on January 18, 2022. Restricted Stock Units vest upon the director's election or re-election, as applicable, at the 2022 Annual Meeting of Shareholders and will be settled in shares of Common Stock on the third anniversary of the date of grant, unless the director has elected to receive settlement of such shares on the date that he or she ceases to be a member of the Board (either in a lump sum or in five equal annual installments beginning on such date). Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 22:56 UTC | BlackRock Inc. BLK · Entity 12961 | GrantCommon Stock | 35 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-000644 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,584 F1 · shares: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $915.56 per share which was the closing price of the stock on December 31, 2021. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 21:27 UTC | IHS Markit Ltd. INFO · Entity 129710 | GrantCommon Shares | 228 | $0.00 | $0.00 |
DisclosureSEC source: 0001598014-21-000150 · wf-form4_163977640178526.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,119 F1 · kind: Quarterly award of Deferred Stock Units elected in lieu of cash retainer and granted pursuant to the IHS Markit Ltd. 2014 Equity Incentive Award Plan. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 22:12 UTC | BlackRock Inc. BLK · Entity 12961 | GrantCommon Stock | 39 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-026513 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,549 F1 · shares: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $838.66 per share which was the closing price of the stock on September 30, 2021. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 20:46 UTC | IHS Markit Ltd. INFO · Entity 129710 | GrantCommon Shares | 246 | $0.00 | $0.00 |
DisclosureSEC source: 0001598014-21-000121 · wf-form4_163182520234127.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,891 F1 · kind: Quarterly award of Deferred Stock Units elected in lieu of cash retainer and granted pursuant to the IHS Markit Ltd. 2014 Equity Incentive Award Plan. Read SEC document |
| June 30, 2021 Filed Jun 30, 2021 21:11 UTC | Royalty Pharma plc RPRX · Entity 3100 | GrantClass A Ordinary Shares | 871 | $43.04 | $37,489.23 |
DisclosureSEC source: 0000950103-21-009780 · dp153692_4-ford.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,597 F1 · price: Reflects Class A Ordinary Shares issued to the Reporting Person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:31 UTC | BlackRock Inc. BLK · Entity 12961 | GrantCommon Stock | 44 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-021252 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,510 F1 · shares: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $874.97 per share which was the closing price of the stock on June 30, 2021. Read SEC document |
| June 25, 2021 Filed Jun 30, 2021 00:29 UTC | Royalty Pharma plc RPRX · Entity 3100 | GrantClass A Ordinary Shares | 5,726 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-21-009690 · dp153557_4-ford.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,726 F1 · shares: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 20:18 UTC | IHS Markit Ltd. INFO · Entity 129710 | GrantCommon Shares | 280 | $0.00 | $0.00 |
DisclosureSEC source: 0001598014-21-000092 · wf-form4_162396109182516.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,645 F1 · kind: Quarterly award of Deferred Stock Units elected in lieu of cash retainer and granted pursuant to the IHS Markit Ltd. 2014 Equity Incentive Award Plan. Read SEC document |
| May 05, 2021 Filed May 7, 2021 20:16 UTC | IHS Markit Ltd. INFO · Entity 129710 | GrantCommon Shares | 1,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001598014-21-000064 · wf-form4_162041855035195.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,365 F1 · kind: Annual award of restricted stock units granted pursuant to the IHS Markit Ltd. 2014 Equity Incentive Award Plan. Read SEC document |
| March 31, 2021 Filed Apr 5, 2021 22:45 UTC | BlackRock Inc. BLK · Entity 12961 | GrantCommon Stock | 47 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-013259 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,466 F1 · shares: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $753.96 per share which was the closing price of the stock on March 31, 2021. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 21:59 UTC | IHS Markit Ltd. INFO · Entity 129710 | GrantCommon Shares | 324 | $0.00 | $0.00 |
DisclosureSEC source: 0001598014-21-000039 · wf-form4_161601831633342.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,685 F1 · kind: Quarterly award of Deferred Stock Units elected in lieu of cash retainer and granted pursuant to the IHS Markit Ltd. 2014 Equity Incentive Award Plan. Read SEC document |
| January 15, 2021 Filed Jan 16, 2021 02:17 UTC | BlackRock Inc. BLK · Entity 12961 | GrantCommon Stock | 325 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-001808 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,419 F1 · shares: Restricted Stock Units granted to Non-employee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $739.22 per share which was the average of the high and low price per share of Common Stock on January 15, 2021. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 21:22 UTC | BlackRock Inc. BLK · Entity 12961 | GrantCommon Stock | 48 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000524 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,094 F1 · shares: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $721.54 per share which was the closing price of the stock on December 31, 2020. Read SEC document |
| December 16, 2020 Filed Feb 27, 2021 00:44 UTC | Royalty Pharma plc RPRX · Entity 3100 | OtherClass A Ordinary Shares | 42,101 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-21-003201 · dp146950_4-ford.xml · nonDerivative · entry 2 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Groton Restricted Fund LP Disclosed balance after: 539,769 F4 · kind: Represents a forfeiture of Class A Ordinary Shares based on the Class A Ordinary Shares attaining a 20-trading day volume weighted average price of $32.30 or more after December 15, 2020 and on or before December 15, 2023. F4 · price: Represents a forfeiture of Class A Ordinary Shares based on the Class A Ordinary Shares attaining a 20-trading day volume weighted average price of $32.30 or more after December 15, 2020 and on or before December 15, 2023. F3 · ownership.nature: The Reporting Person has a private membership interest in Madison Park Capital, LLC ("MPC"), a U.S. based entity within the General Atlantic private equity group, and is an officer and a member of the Board of Managers of MPC. MPC maintains an investment as a limited partner of Groton Restricted Fund LP. The Reporting Person disclaims ownership of such ordinary shares except to the extent he has a pecuniary interest therein. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 22:21 UTC | IHS Markit Ltd. INFO · Entity 129710 | GrantCommon Shares | 309 | $0.00 | $0.00 |
DisclosureSEC source: 0001598014-20-000218 · wf-form4_160824368555843.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,361 F1 · kind: Quarterly award of Deferred Stock Units elected in lieu of cash retainer and granted pursuant to the IHS Markit Ltd. 2014 Equity Incentive Award Plan. Read SEC document |
| October 20, 2020 Filed Feb 27, 2021 00:44 UTC | Royalty Pharma plc RPRX · Entity 3100 | ConversionLP interests in RPI US Partners 2019, LP · Derivative | 58,187 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950103-21-003201 · dp146950_4-ford.xml · derivative · entry 4 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Groton Restricted Fund LP Disclosed balance after: 0 Underlying: Class A Ordinary Shares · 581,870 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These Class A Ordinary Shares were received in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") was exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed was exchanged for one Class A Ordinary Share of the Issuer. This exchange was made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value was paid in connection with the exchange. F1 · price: These Class A Ordinary Shares were received in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") was exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed was exchanged for one Class A Ordinary Share of the Issuer. This exchange was made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value was paid in connection with the exchange. F9 · derivative.exercise_date: Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged upon such exchange for one Class A Ordinary Share of the Issuer for no additional value. F9 · derivative.expiration_date: Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged upon such exchange for one Class A Ordinary Share of the Issuer for no additional value. F10 · balance_after: These holdings have been adjusted to reflect a transfer of 17,940 RPI US LP Interests from Groton Restricted Fund LP to Steamboat Park Investments, LLC ("SPI") on October 20, 2020 in distribution of SPI's limited partnership interest in Groton Restricted Fund LP F1 · ownership.nature: These Class A Ordinary Shares were received in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") was exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed was exchanged for one Class A Ordinary Share of the Issuer. This exchange was made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value was paid in connection with the exchange. Read SEC document |
| October 20, 2020 Filed Feb 27, 2021 00:44 UTC | Royalty Pharma plc RPRX · Entity 3100 | ConversionClass A Ordinary Shares | 581,870 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-21-003201 · dp146950_4-ford.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Groton Restricted Fund LP Disclosed balance after: 581,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These Class A Ordinary Shares were received in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") was exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed was exchanged for one Class A Ordinary Share of the Issuer. This exchange was made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value was paid in connection with the exchange. F1 · price: These Class A Ordinary Shares were received in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") was exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed was exchanged for one Class A Ordinary Share of the Issuer. This exchange was made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value was paid in connection with the exchange. F2 · balance_after: Following the reported transaction, included 42,101 Class A Ordinary Shares that were subject to forfeiture if and when the Class A Ordinary Shares attained a 20-trading day volume weighted average price of $32.30 or more after December 15, 2020 and on or before December 15, 2023. F3 · ownership.nature: The Reporting Person has a private membership interest in Madison Park Capital, LLC ("MPC"), a U.S. based entity within the General Atlantic private equity group, and is an officer and a member of the Board of Managers of MPC. MPC maintains an investment as a limited partner of Groton Restricted Fund LP. The Reporting Person disclaims ownership of such ordinary shares except to the extent he has a pecuniary interest therein. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 20:08 UTC | BlackRock Inc. BLK · Entity 12961 | GrantCommon Stock | 62 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026259 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,046 F1 · shares: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $563.55 per share which was the closing price of the stock on September 30, 2020. Read SEC document |
| September 10, 2020 Filed Sep 14, 2020 22:24 UTC | IHS Markit Ltd. INFO · Entity 129710 | GrantCommon Shares | 281 | $0.00 | $0.00 |
DisclosureSEC source: 0001598014-20-000187 · wf-form4_160012223035602.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,052 F1 · kind: Quarterly award of Deferred Stock Units elected in lieu of cash retainer and granted pursuant to the IHS Markit Ltd. 2014 Equity Incentive Award Plan. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 21:12 UTC | BlackRock Inc. BLK · Entity 12961 | GrantCommon Stock | 64 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-021010 · form4.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,984 F1 · shares: Common Stock granted to Nonemployee Directors under the Second Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $544.09 per share which was the closing price of the stock on June 30, 2020. Read SEC document |
| June 18, 2020 Filed Jun 23, 2020 01:55 UTC | Royalty Pharma plc RPRX · Entity 3100 | PurchaseClass A Ordinary Shares | 1,500,000 | $28.00 | $42,000,000.00 |
DisclosureSEC source: 0000950103-20-012149 · dp130795_4-ford.xml · nonDerivative · entry 1 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · GA RP Holding, L.P. Disclosed balance after: 1,500,000 F1 · ownership.nature: The Reporting Person is employed by an entity affiliated with GA RP Holding, L.P. ("GA RP Holding"). The limited partners of GA RP Holding that share beneficial ownership of the ordinary shares held by GA RP Holding are GAP Coinvestments CDA, L.P. ("GAPCO CDA"), GAP Coinvestments III, LLC ("GAPCO III"), GAP Coinvestments IV, L.P. ("GAPCO IV"), GAP Coinvestments V, LLC ("GAPCO V"), General Atlantic Partners (Bermuda) IV, L.P. ("GAP Bermuda IV"), General Atlantic Partners (Bermuda) EU, L.P. ("GAP Bermuda EU") and General Atlantic Partners (Lux), SCSp ("GAP Lux"). GA RP Holding, Ltd. ("GA RP Ltd.") is the general partner of GA RP Holding. General Atlantic LLC ("GA LLC") is the managing member of GAPCO III, GAPCO IV and GAPCO V and the general partner of GAPCO CDA. General Atlantic GenPar (Lux), SCSp ("GA GenPar Lux") is the general partner of GAP Lux, and General Atlantic (Lux) S.a.r.l ("GA Lux Sarl") is the general partner of GA GenPar Lux. F10 · ownership.nature: General Atlantic GenPar (Bermuda), L.P. ("GA GenPar Bermuda") is the sole shareholder of GA Lux Sarl, and the general partner of GAP Bermuda IV and GAP Bermuda EU. GAP (Bermuda) Limited is the general partner of GA GenPar Bermuda and the sole shareholder of GA RP Ltd. There are eight members of the management committee of GA LLC (the "GA Management Committee"), and the GA Management Committee is ultimately responsible for the management of GAP (Bermuda) Limited. F11 · ownership.nature: The Reporting Person is a member of the GA Management Committee and is Chief Executive Officer and a Managing Director of GA LLC. GA LLC, GA GenPar Bermuda, GAP (Bermuda) Limited, GAPCO III, GAPCO IV, GAPCO V, GAPCO CDA, GAP Bermuda IV, GAP Bermuda EU, GAP Lux, GA RP Ltd, GA GenPar Lux and GA Lux Sarl are a "group" within the meaning of Rule 13d-5 of the Securities Exchange Act of 1934, as amended. Each of the members of the GA Management Committee disclaims ownership of the ordinary shares except to the extent he or she has a pecuniary interest therein. Read SEC document |
| June 15, 2020 Filed Jun 23, 2020 01:55 UTC | Royalty Pharma plc RPRX · Entity 3100 | GrantLP interests in RPI US Partners 2019, LP · Derivative | 76,127 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950103-20-012149 · dp130795_4-ford.xml · derivative · entry 4 FORD WILLIAM E · CIK 0001193345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Groton Restricted Fund LP Disclosed balance after: 76,127 Underlying: Class A Ordinary Shares · 761,270 shares Expires not disclosed F2 · kind: The Reporting Person acquired beneficial ownership of Class B Interests in Royalty Pharma Holdings Ltd. ("Holdings") and became entitled to indirect rights to exchange such Class B Interests for Class A Ordinary Shares of the Issuer in connection with a reorganization prior to closing of the Issuer's initial public offering (as more fully described in the Issuer's Registration Statement on Form S-1 (File No. 333-238632)). The reorganization involved the exchange of interests in Royalty Pharma Investments 2019 ICAV held by RPI US Partners 2019, LP ("RPI US LP") for interests in Holdings. The reorganization and the acquisition of these exchange rights occurred on June 15, 2020. F3 · derivative.exercise_date: Represents limited partnership interests in RPI US LP ("RPI US LP Interests"). Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged upon such exchange for one Class A Ordinary Share of the Issuer for no additional value. F3 · derivative.expiration_date: Represents limited partnership interests in RPI US LP ("RPI US LP Interests"). Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged upon such exchange for one Class A Ordinary Share of the Issuer for no additional value. F8 · balance_after: Includes 5,512 RPI US LP Interests that are subject to forfeiture if and when the Class A Ordinary Shares attain a 20-trading day volume weighted average price of $32.30 or more after December 15, 2020 and on or before December 15, 2023. The amount of this forfeiture scales linearly from 0% at $20.51 per share to 100% at $32.30 per share. F9 · ownership.nature: The Reporting Person has a private membership interest in Madison Park Capital, LLC ("MPC"), a U.S. based entity within the General Atlantic private equity group, and is an officer and a member of the Board of Managers of MPC. Each of SPI and MPC maintains an investment as a limited partner of Groton Restricted Fund LP. The Reporting Person disclaims ownership of such ordinary shares except to the extent he has a pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.